Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,008 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Using of magnetic resonance enterography in the management of Crohn's disease of the small intestine: first year of experience.
Mendoza JL, González-Lama Y, Taxonera C, Suárez-Ferrer C, Matute F, Vera MI, López-Palacios N, Rodríguez P, Calvo M, Méndez R, Pastrana M, González C, Lana R, Rodríguez R, Abreu L. Mendoza JL, et al. Among authors: abreu l. Rev Esp Enferm Dig. 2012 Dec;104(11):578-83. doi: 10.4321/s1130-01082012001100005. Rev Esp Enferm Dig. 2012. PMID: 23368649 Free article.
Predictors of response to infliximab in patients with fistulizing Crohn's disease.
Luna-Chadid M, Pérez Calle JL, Mendoza JL, Vera MI, Bermejo AF, Sánchez F, López San Román A, Froilán C, González-Lara V, García-Paredes J, Fernández-Blanco I, Abreu L, Casis B, Solís Herruzo JA, Gisbert JP, Maté Jiménez J. Luna-Chadid M, et al. Among authors: abreu l. Rev Esp Enferm Dig. 2004 Jun;96(6):379-81; 382-4. doi: 10.4321/s1130-01082004000600003. Rev Esp Enferm Dig. 2004. PMID: 15230667 Free article. English, Spanish.
Open-label infliximab therapy in Crohn's disease: a long-term multicenter study of efficacy, safety and predictors of response.
González-Lama Y, López-San Román A, Marín-Jiménez I, Casis B, Vera I, Bermejo F, Pérez-Calle JL, Taxonera C, Martínez-Silva F, Menchén L, Martínez-Montiel P, Calvo M, Carneros JA, López P, Mendoza JL, Milicua JM, Huerta A, Sánchez F, Abreu L, López-Palacios N, Maté J, Gisbert JP; Group for the Study of Inflammatory Bowel Diseases from Madrid (ENICMAD). González-Lama Y, et al. Among authors: abreu l. Gastroenterol Hepatol. 2008 Aug-Sep;31(7):421-6. doi: 10.1157/13125587. Gastroenterol Hepatol. 2008. PMID: 18783686
Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience.
Fortea-Ormaechea JI, González-Lama Y, Casis B, Chaparro M, López Serrano P, Van Domselaar M, Bermejo F, Pajares R, Ponferrada A, Vera MI, Martínez Montiel P, Gisbert JP, Pérez-Calle JL, López San Román A, Abreu L, Menchén LA, Marín-Jiménez I. Fortea-Ormaechea JI, et al. Among authors: abreu l. Gastroenterol Hepatol. 2011 Aug-Sep;34(7):443-8. doi: 10.1016/j.gastrohep.2011.04.001. Epub 2011 Jul 2. Gastroenterol Hepatol. 2011. PMID: 21724297
Timing of Thiopurine or Anti-TNF Initiation Is Associated with the Risk of Major Abdominal Surgery in Crohn's Disease: A Retrospective Cohort Study.
González-Lama Y, Suárez C, González-Partida I, Calvo M, Matallana V, de la Revilla J, Magaz M, Bernardo C, Agudo B, Ibarrola P, Relea L, Arévalo J, Vera MI, Abreu L. González-Lama Y, et al. Among authors: abreu l. J Crohns Colitis. 2016 Jan;10(1):55-60. doi: 10.1093/ecco-jcc/jjv187. Epub 2015 Oct 31. J Crohns Colitis. 2016. PMID: 26520164
Visceral leishmaniasis as an unusual infectious complication in a patient with Crohn's disease treated with infliximab.
Hernández M, González-Lama Y, Ramos A, Martínez-Ruiz R, Calvo M, Matallana V, Vera MI, Suarez C, Blázquez I, Abreu L. Hernández M, et al. Among authors: abreu l. Gastroenterol Hepatol. 2015 Jun-Jul;38(6):411-2. doi: 10.1016/j.gastrohep.2014.08.003. Epub 2014 Oct 16. Gastroenterol Hepatol. 2015. PMID: 25443540 No abstract available.
1,008 results